🙉 NASDAQ: BSGM a Multi-Day MONSTER Tip!

NASDAQ: BSGM could go INSANE by NEXT WEEK! Make sure you watch it! [View online]( [UNSUBSCRIBE]( NEW TIP: ** NASDAQ: BSGM ** Greetings All, Before I get into this report... Want to make sure you watch NASDAQ: BSGM with the thought in mind that NEXT WEEK we could be in for a HUGE MOMENTUM Rally!! We are making this an EARLY BIRD Tip! TIME TO GET THOSE BIG MOVERS ON YOUR SCREEN AGAIN!! A 10-year Strategic Agreement with Mayo Clinic, a Solution Already Cleared with the FDA Makes This Small Cap Medtech Company a Remarkable Find on the NASDAQ…  Greetings Investors, Headlines have been rampant for biotech and pharma stocks amid the pandemic with cutting-edge medicines. One rising arena in healthcare that isn't getting talked about enough is bioelectronic medicine, which is a rapidly growing segment of healthcare that explores how targeted electrical signals can harness the body’s natural mechanisms to diagnose and treat a range of diseases. This industry covers a wide range of health and medical instruments used in the treatment, mitigation, diagnosis and prevention of diseases and physical conditions, and it continues to develop rapidly. A small-cap NASDAQ company has emerged, trading under $1, that is seeking to serve a vital market with a device that could be a game changer and is targeting the $4.6B electrophysiology (EP) market.  [Svita Subramanian,]( head of equity and quantitative strategy at BofA Securities, likes the defensive nature of healthcare stocks, as well as their ability to maintain pricing power. "We believe the sector is well-positioned amid looming recession risks," Subramanian says. "Healthcare offers growth, defense, and yield at a reasonable price: GARP (growth at a reasonable price), DARP (defense at a reasonable price), and YARP (yield at a reasonable price)." Looking into the future, this company is on a solid path to commercial growth, publishing more clinical results, expanding their product pipeline, and growing internationally! []( BioSig Technologies, Inc. NASDAQ: BSGM An Unmatched Perspective in Bioelectronic Medicine That Ensures Anything of Potential Significant Never Gets Overlooked! BioSig Technologies (NASDAQ: BSGM) is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals. The company offers an unmatched perspective in bioelectronic medicine that ensures anything of potential significance never gets overlooked. A rising field in the massive healthcare industry is bioelectronic medicine, which is a rapidly growing segment of healthcare that explores how targeted electrical signals can harness the body’s natural mechanisms to diagnose and treat a range of diseases. The space, which includes familiar devices such as pacemakers, is expected to [exceed a staggering $60 billion market by 2029!]( Bioelectronic medicine represents an entire approach to detecting and treating disease – using electrical pulses and the body’s own mechanisms as an adjunct or alternative to drugs and medical procedures. As a new, rapidly growing field of healthcare, BSGM explores how targeted electrical signals in the body can help to diagnose and treat a wide range of diseases, from diabetes to even depression. Based on their unique enabling technology and core competency in signal processing, the company's initial focus is on heart disease and the fast-growing electrophysiology device market. The PURE EP™ System The PURE EP system is BSGM’s first product and is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory. [FULL PROFILE on NASDAQ: BSGM]( Copyright 2022 © TopStockTips is owned and operated by Top Stock Tips Ltd. [Disclaimer and PrivacyÂ]( more Information please contact editor@topstocktips.com This website provides information about the stock market and other investments. This website does not provide investment advice and should not be used as a replacement for investment advice from a qualified professional. This website is for informational purposes only. The Author of this website is not a registered investment advisor and does not offer investment advice. You, the reader, bear responsibility for your own investment decisions and should seek the advice of a qualified securities professional before making any investment. This communication includes advertising material and PAID ADVERTISEMENTS provided to our subscribers. Copyright 2022 © TopStockTips.com is 50% owned and operated by the owner of CareBear Marketing Group LLC. Disclaimer and Privacy For more Information please contact Support@TopStockTips.com Company Address: 26 Downing Street, Newark NJ 07105. This website provides information about the stock market and other investments. This website does not provide investment advice and should not be used as a replacement for investment advice from a qualified professional. This website is for informational purposes only. The Author of this website is not a registered investment advisor and does not offer investment advice. You, the reader, bear responsibility for your own investment decisions and should seek the advice of a qualified securities professional before making any investment. Nothing on this website should be considered personalized financial advice. Any investments recommended here in should be made only after consulting with your personal investment advisor and only after performing your own research and due diligence, including reviewing the prospectus or financial statements of the issuer of any security.  CareBear Marketing Group, its managers, its employees, affiliates, and assigns (collectively "The Company") do not make any guarantee or warranty about the advice provided on this website or what is otherwise advertised above. To the maximum extent permitted by law, the Company disclaims all liability in the event any information, commentary, analysis, opinions, advice and/or recommendations provided herein prove to be inaccurate, incomplete, or unreliable, or result in any investment or other losses. You received this message as part of your subscription to TST. TST is a free financial news and information website. We do not directly sell any products or offer any personal financial advice, nor do we advocate the purchase or sale of any security or investment for any specific individual. We also do not make any guarantee or warranty about what is advertised above. If you have questions or concerns about a product you’ve seen in one of our emails, we encourage you to reach out to that company directly.  Disclaimer – Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated, and edited by CareBear Marketing Group. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” or “TST” refers to CareBear Marketing Group. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and are therefore unqualified to give investment recommendations. Companies with low prices per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service, you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader to take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and its owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares, we will list the information relevant to the stock and the number of shares here. We do not own any shares of BSGM. We have been compensated Seventy-Five Thousand Dollars Cash ($75,000) by a third party Open Market Media Group for a 2 day marketing program regarding BSGM with a start date of 6/22/22 to 6/23/22. This compensation is a major conflict of interest in our ability to be unbiased regarding our alerts. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, TST often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice. , Rua Frei Tome de Jesus N18 1Dto, 1700-215, Lisboa, Portugal You may [unsubscribe]( or [change your contact details]( at any time. Powered by:[GetResponse](